Differential expression patterns of proinflammatory and antiinflammatory mediators during atherogenesis in mice

被引:70
作者
Veillard, NR [1 ]
Steffens, S [1 ]
Burger, F [1 ]
Pelli, G [1 ]
Mach, F [1 ]
机构
[1] Univ Hosp Geneva, Fdn Med Res, Dept Med, Div Cardiol, CH-1211 Geneva, Switzerland
关键词
atherogenesis; inflammation; cytokines; chemokines;
D O I
10.1161/01.ATV.0000146532.98235.e6
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective - Recent advances support the current view of atherosclerosis as an inflammatory process that initiates and promotes lesion development to the point of acute thrombotic complications and clinical events. ApoE-deficient mice are a valuable model for studying the involvement of inflammatory mediators during atherogenesis. In this study, we investigated the correlation between atherosclerotic plaque development and expression of important pro- and antiinflammatory mediators during progression of atherosclerosis in ApoE-/- mice. Methods and Results - Expression of proinflammatory cytokines, chemokines, and chemokine receptors within aortic lesions increased during atherogenesis, as detected by real-time quantitative reverse-transcription polymerase chain reaction. In parallel, the number of inflammatory cells within lesions increased together with serum cholesterol and body weight. Interestingly, the majority of inflammatory mediators investigated reached their maximum expression values at 10 weeks of diet, followed by continuous decrease of their expression levels, whereas atherosclerotic plaque size further increased. We show that the expression pattern of these different inflammatory mediators mainly correlates with the amount of inflammatory cells present within the atherosclerotic lesions. Conclusion - Atherosclerosis might result from an imbalance between pro- and antiinflammatory mediators in response to endothelial injury induced by cholesterol-rich diet. These data provide important information on the expression kinetics of inflammatory mediators and point out the possible role of antiinflammatory cells during atherogenesis.
引用
收藏
页码:2339 / 2344
页数:6
相关论文
共 29 条
[11]   Apoptotic cell death in atherosclerosis [J].
Littlewood, TD ;
Bennett, MR .
CURRENT OPINION IN LIPIDOLOGY, 2003, 14 (05) :469-475
[12]   Chemokines - Chemotactic cytokines that mediate inflammation [J].
Luster, AD .
NEW ENGLAND JOURNAL OF MEDICINE, 1998, 338 (07) :436-445
[13]   Differential expression of three T lymphocyte-activating CXC chemokines by human atheroma-associated cells [J].
Mach, F ;
Sauty, A ;
Iarossi, AS ;
Sukhova, GK ;
Neote, K ;
Libby, P ;
Luster, AD .
JOURNAL OF CLINICAL INVESTIGATION, 1999, 104 (08) :1041-1050
[14]   Induction of a regulatory T cell type 1 response reduces the development of atherosclerosis in apolipoprotein E-knockout mice [J].
Mallat, Z ;
Gojova, A ;
Brun, V ;
Esposito, B ;
Fournier, N ;
Cottrez, F ;
Tedgui, A ;
Groux, H .
CIRCULATION, 2003, 108 (10) :1232-1237
[15]   Lesion progression in apoE-deficient mice:: Implication of chemokines and effect of the AT1 angiotensin II receptor antagonist irbesartan [J].
Martin, G ;
Dol, F ;
Marés, AM ;
Berezowski, V ;
Staels, B ;
Hum, DW ;
Schaeffer, P ;
Herbert, JM .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2004, 43 (02) :191-199
[16]   Th1-specific cell surface protein Tim-3 regulates macrophage activation and severity of an autoimmune disease [J].
Monney, L ;
Sabatos, CA ;
Gaglia, JL ;
Ryu, A ;
Waldner, H ;
Chernova, T ;
Manning, S ;
Greenfield, EA ;
Coyle, AJ ;
Sobel, RA ;
Freeman, GJ ;
Kuchroo, VK .
NATURE, 2002, 415 (6871) :536-541
[17]   Interleukin-10 and the interleukin-10 receptor [J].
Moore, KW ;
Malefyt, RD ;
Coffman, RL ;
O'Garra, A .
ANNUAL REVIEW OF IMMUNOLOGY, 2001, 19 :683-765
[18]   MACROPHAGE INFILTRATION IN ACUTE CORONARY SYNDROMES - IMPLICATIONS FOR PLAQUE RUPTURE [J].
MORENO, PR ;
FALK, E ;
PALACIOS, IF ;
NEWELL, JB ;
FUSTER, V ;
FALLON, JT .
CIRCULATION, 1994, 90 (02) :775-778
[19]   Temporal relationships between circulating levels of CC and CXC chemokines and developing atherosclerosis in apolipoprotein E*3 Leiden mice [J].
Murphy, N ;
Bruckdorfer, KR ;
Grimsditch, DC ;
Overend, P ;
Vidgeon-Hart, M ;
Groot, PHE ;
Benson, GM ;
Graham, A .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2003, 23 (09) :1615-1620
[20]   From vulnerable plaque to vulnerable patient - A call for new definitions and risk assessment strategies: Part II [J].
Naghavi, M ;
Libby, P ;
Falk, E ;
Casscells, SW ;
Litovsky, S ;
Rumberger, J ;
Badimon, JJ ;
Stefanadis, C ;
Moreno, P ;
Pasterkamp, G ;
Fayad, Z ;
Stone, PH ;
Waxman, S ;
Raggi, P ;
Madjid, M ;
Zarrabi, A ;
Burke, A ;
Yuan, C ;
Fitzgerald, PJ ;
Siscovick, DS ;
de Korte, CL ;
Aikawa, M ;
Airaksinen, KEJ ;
Assmann, G ;
Becker, CR ;
Chesebro, JH ;
Farb, A ;
Galis, ZS ;
Jackson, C ;
Jang, IK ;
Koenig, W ;
Lodder, RA ;
March, K ;
Demirovic, J ;
Navab, M ;
Priori, SG ;
Rekhter, MD ;
Bahr, R ;
Grundy, SM ;
Mehran, R ;
Colombo, A ;
Boerwinkle, E ;
Ballantyne, C ;
Insull, W ;
Schwartz, RS ;
Vogel, R ;
Serruys, PW ;
Hansson, GK ;
Faxon, DP ;
Kaul, S .
CIRCULATION, 2003, 108 (15) :1772-1778